| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 303 | 344 | 360 | 392 | 335 | 356 | 350 | 309 | 353 | 404 | 435 | 454 | 412 | 405 | 105 | 367 | 337 | 342 | 402 | 385 | 354 | 426 | 212 | 301 | 364 | 347 | 302 | 279 | 320 | 314 | 349 | 393 | 384 |
| Expenses | 263 | 295 | 294 | 321 | 267 | 283 | 266 | 247 | 265 | 300 | 321 | 345 | 315 | 330 | 199 | 349 | 318 | 311 | 350 | 332 | 333 | 393 | 436 | 412 | 322 | 286 | 243 | 228 | 262 | 279 | 318 | 330 | 320 |
| EBITDA | 40 | 49 | 66 | 71 | 68 | 73 | 84 | 62 | 88 | 104 | 114 | 109 | 97 | 75 | -94 | 18 | 20 | 31 | 52 | 53 | 21 | 34 | -224 | -111 | 43 | 62 | 59 | 51 | 58 | 35 | 31 | 63 | 65 |
| Operating Profit % | 13 % | 14 % | 17 % | 17 % | 19 % | 19 % | 23 % | 17 % | 24 % | 25 % | 25 % | 22 % | 22 % | 18 % | -98 % | 3 % | 4 % | 8 % | 11 % | 13 % | 5 % | 8 % | -106 % | -38 % | 12 % | 18 % | 19 % | 17 % | 18 % | 11 % | 9 % | 15 % | 16 % |
| Depreciation | 19 | 19 | 21 | 23 | 23 | 24 | 24 | 24 | 26 | 28 | 27 | 27 | 28 | 28 | 28 | 28 | 28 | 29 | 28 | 27 | 26 | 26 | 26 | 25 | 25 | 25 | 25 | 24 | 24 | 25 | 26 | 26 | 27 |
| Interest | 18 | 20 | 23 | 22 | 19 | 20 | 19 | 20 | 20 | 19 | 21 | 25 | 19 | 17 | 18 | 22 | 23 | 22 | 24 | 22 | 25 | 24 | 25 | 31 | 31 | 28 | 27 | 29 | 24 | 21 | 23 | 28 | 22 |
| Profit Before Tax | 3 | 9 | 22 | 26 | 27 | 29 | 41 | 18 | 42 | 57 | 66 | 57 | 50 | 30 | -140 | -31 | -31 | -19 | 1 | 5 | -29 | -17 | -275 | -167 | -14 | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 |
| Tax | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33 | -15 | -9 | 0 | 1 | -10 | 0 | 0 | 89 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 3 | 9 | 22 | 26 | 27 | 29 | 41 | 18 | 42 | 57 | 66 | 57 | 50 | 30 | -140 | 2 | -17 | -10 | 0 | 4 | -19 | -17 | -275 | -255 | -14 | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 |
| EPS in ₹ | 0.23 | 3.47 | 8.96 | 10.17 | 10.29 | 11.21 | 16.00 | 6.78 | 15.75 | 19.21 | 18.47 | 15.57 | 13.95 | 8.27 | -38.93 | 0.53 | -4.56 | -2.77 | 0.12 | 1.05 | -5.43 | -4.77 | -72.07 | -70.93 | -3.50 | 2.54 | 2.03 | -0.93 | 2.46 | -2.36 | -3.98 | 2.20 | 3.52 |
Solara Active Pharma Sciences
Solara Active Pharma Sciences
515.85
+2.30
(0.45%)
Market Cap
2,461.21 Cr
PE Ratio
-1,508.24
Volume
1,11,052.00
Day High - Low
523.65 - 513.00
52W High-Low
712.00 - 422.00
Key Fundamentals
Market Cap
2,461.21 Cr
EPS
-1.68
PE Ratio
-1,508.24
PB Ratio
1.95
Book Value
262.87
EBITDA
180.86
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
0.05
Debt to Equity
0.89
Actual
Company News
View All News
Solara Active Pharma Plans INR 55-60 Cr Capex in FY2710 days ago
Solara Active Pharma Sciences plans INR 55-60 crores capex in FY27, with INR 40 crores for debottlenecking and INR 10-15 crores for maintenance, followed by INR 40-50 crores annually in FY28 and FY29.
Solara Active Pharma uploads Q1 FY27 call
10 days ago
10 days agoSolara Active Pharma Sciences Ltd uploaded the audio recording of its Q1 FY27 earnings call held on July 23, 2026, to its website for investor access.
Solara appoints Ajit Manocha as CIOJul 23, 2026
Jul 23, 2026Solara Active Pharma Sciences Ltd appointed Ajit Manocha as Chief Information Officer effective August 10, 2026. He brings over 33 years of experience in technology and life sciences.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,963.50 | #1 4,71,109.42 | 39.39 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 57.67 | |
8,585.00 | 2,27,904.78 | 83.29 | 11,067.00 | 13.95 | 2,568 | 65.50 | 87.46 | |
5,050.00 | 1,92,085.77 | 90.03 | 13,886.20 | 20.34 | 2,138 | 3.28 | 59.47 | |
1,474.40 | 1,19,108.71 | 35.46 | 29,044.60 | 2.24 | 3,870 | -39.18 | 61.69 | |
1,121.00 | 1,12,798.83 | 21.93 | 27,657.90 | 17.64 | 5,026 | 7.82 | 50.99 | |
2,393.00 | 1,09,415.75 | #1 20.61 | 29,038.90 | #1 26.75 | 5,356 | 87.72 | 46.72 | |
2,483.00 | 1,02,546.90 | 49.34 | 14,636.40 | 14.85 | 1,938 | 29.13 | 46.36 | |
1,180.00 | 98,490.95 | 30.09 | 35,058.60 | 3.90 | 4,158 | -69.10 | 39.90 | |
1,811.40 | 97,789.62 | 90.00 | 6,867.80 | 22.01 | 890 | #1 123.93 | 80.59 | |
1,554.70 | 89,454.00 | 26.19 | 33,384.70 | 3.21 | 3,376 | 1.99 | 51.68 |
Growth Rate
Revenue Growth
5.95 %
Net Income Growth
-1,582.00 %
Cash Flow Change
95.48 %
ROE
-100.08 %
ROCE
-125.90 %
EBITDA Margin (Avg.)
-20.83 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 1,822 | 1,960 | 2,154 | 2,614 | 2,945 | 2,899 | 2,351 | 2,232 | 2,333 |
| Fixed Assets | 1,086 | 1,218 | 1,397 | 1,382 | 1,356 | 1,364 | 1,268 | 1,193 | 1,077 |
| Current Assets | 608 | 648 | 672 | 1,058 | 1,239 | 1,188 | 801 | 729 | 858 |
| Capital Work in Progress | 72 | 40 | 41 | 88 | 239 | 239 | 256 | 280 | 205 |
| Investments | 1 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 318 |
| Other Assets | 663 | 702 | 716 | 1,144 | 1,350 | 1,295 | 825 | 757 | 0 |
| Total Equity & Liabilities | 1,822 | 1,960 | 2,154 | 2,614 | 2,945 | 2,899 | 2,351 | 2,232 | 2,333 |
| Current Liabilities | 738 | 656 | 730 | 789 | 1,063 | 1,101 | 1,243 | 944 | 894 |
| Non Current Liabilities | 315 | 344 | 333 | 232 | 354 | 296 | 172 | 191 | 183 |
| Total Equity | 769 | 960 | 1,090 | 1,593 | 1,527 | 1,502 | 937 | 1,097 | 1,253 |
| Reserve & Surplus | 739 | 826 | 963 | 1,553 | 1,489 | 1,464 | 898 | 1,054 | 1,208 |
| Share Capital | 25 | 26 | 27 | 36 | 36 | 36 | 36 | 40 | 45 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 32 | 30 | -20 | 142 | -151 | -38 | -0 | -5 |
| Investing Activities | -86 | -113 | -359 | -106 | -243 | -81 | -4 | -37 |
| Operating Activities | 49 | 166 | 242 | 156 | -242 | 156 | 109 | 213 |
| Financing Activities | 68 | -23 | 97 | 93 | 334 | -113 | -106 | -181 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | May 2026 | Jun 2026 |
| Promoter | 44.11 % | 41.07 % | 41.07 % | 39.51 % | 39.71 % | 40.40 % | 40.40 % | 40.40 % | 40.97 % | 39.31 % | 37.19 % | 30.49 % | 30.49 % | 37.27 % | 37.27 % | 37.23 % | 37.94 % | 42.01 % | 42.01 % | 42.00 % | 42.00 % | 42.00 % | 41.93 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 15.80 % | 14.00 % | 14.25 % | 14.67 % | 14.63 % | 14.25 % | 13.58 % | 11.98 % | 11.59 % | 11.33 % | 11.52 % |
| DIIs | 3.72 % | 6.18 % | 5.55 % | 5.38 % | 3.39 % | 2.85 % | 2.56 % | 3.01 % | 2.22 % | 1.75 % | 1.75 % | 1.71 % | 2.97 % | 2.83 % | 3.38 % | 3.19 % | 2.61 % | 2.62 % | 2.69 % | 3.64 % | 3.75 % | 3.78 % | 3.74 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 14.76 % | 14.35 % | 13.84 % | 16.36 % | 17.41 % | 16.61 % | 17.28 % | 16.54 % | 16.23 % | 18.06 % | 19.84 % | 20.95 % | 20.15 % | 19.61 % | 18.83 % | 21.93 % | 23.07 % | 23.47 % | 24.01 % | 24.63 % | 25.03 % | 25.15 % | 25.84 % |
| Others | 37.41 % | 38.40 % | 39.53 % | 38.73 % | 39.48 % | 40.15 % | 39.76 % | 40.04 % | 40.58 % | 40.88 % | 41.22 % | 46.84 % | 30.59 % | 26.29 % | 26.28 % | 22.98 % | 21.74 % | 17.63 % | 17.70 % | 17.74 % | 17.63 % | 17.74 % | 16.97 % |
| No of Share Holders | 58,907 | 67,197 | 65,449 | 73,000 | 77,228 | 82,710 | 83,319 | 79,149 | 76,325 | 75,417 | 74,473 | 72,918 | 73,912 | 78,617 | 71,882 | 83,148 | 75,791 | 74,334 | 72,479 | 71,920 | 70,400 | 70,037 | 70,490 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 5 | 2 | 7 | 0.00 | 3 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 1.22 | 0.16 | 1.14 | 0.00 | 0.88 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Mar 2017 |  Change Of Name | NA | 25 Mar 2017 | 0.00 | 0.00 |
| 20 Aug 2021 |  Dividend | ₹ 3.00 /share | 18 Aug 2021 | 1,484.58 | 1,564.11 |
| 15 May 2024 |  Rights | 1:3 | 15 May 2024 | 465.01 | 503.40 |
| 20 Sept 2024 |  Annual General Meeting | NA | 20 Sept 2024 | 694.40 | 736.35 |
| 21 Oct 2024 |  Quarterly Result Announcement | NA | 21 Oct 2024 | 748.90 | 809.60 |
| 24 Jan 2025 | Quarterly Result Announcement | NA | 24 Jan 2025 | 652.85 | 678.80 |
| 15 May 2025 | Quarterly Result Announcement | NA | 15 May 2025 | 482.35 | 576.30 |
| 25 Jul 2025 | Quarterly Result Announcement | NA | 25 Jul 2025 | 692.85 | 657.35 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 632.10 | 644.30 |
| 05 Nov 2025 | Quarterly Result Announcement | NA | 05 Nov 2025 | 588.45 | 617.40 |
| 06 Feb 2026 | Quarterly Result Announcement | NA | 06 Feb 2026 | 505.55 | 524.15 |
| 15 May 2026 | Quarterly Result Announcement | NA | 15 May 2026 | 515.85 | 506.85 |
| 23 Jul 2026 | Quarterly Result Announcement | NA | 23 Jul 2026 | 577.30 | 535.45 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication10 days ago
10 days agoSubmission Of Machine Readable Copy Of Financial Results For The Quarter Ended June 30 202610 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Monitoring Agency ReportJul 23, 2026
Jul 23, 2026Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30 2026.Jul 23, 2026
Jul 23, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 23, 2026
Jul 23, 2026Intimation About Appointment Of Chief Information Officer (CIO)Jul 23, 2026
Jul 23, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2026
Jul 23, 2026Unaudited Financial Results For The Quarter Ended June 30 2026Jul 23, 2026
Jul 23, 2026Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2026.Jul 23, 2026
Jul 23, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 16, 2026
Jul 16, 2026Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Jul 16, 2026
Jul 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 09, 2026
Jul 09, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2026
Jul 09, 2026Approval Of The Reminder - Cum - Forfeiture NoticeJul 03, 2026
Jul 03, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 26, 2026
Jun 26, 2026Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015 - Transfer Of Equity Shares Of The Company To The IEPFJun 26, 2026
Jun 26, 2026Closure of Trading WindowJun 25, 2026
Jun 25, 2026Announcement under Regulation 30 (LODR)-Credit RatingJun 23, 2026
Jun 23, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 16, 2026
Jun 16, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 16, 2026
Jun 16, 2026Clarification On Volume MovementJun 10, 2026
Jun 10, 2026Clarification sought from Solara Active Pharma Sciences LtdJun 10, 2026
Jun 10, 2026Intimation - Special Window For Transfer And Dematerialisation Of SharesJun 05, 2026
Jun 05, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2026
May 21, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2026
May 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
May 15, 2026Intimation Regarding The Adoption Or Amendments Of PoliciesMay 15, 2026
May 15, 2026Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended March 31 2026.May 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 15, 2026
May 15, 2026Intimation Regarding The Reappointment Of Cost Auditor And Internal AuditorMay 15, 2026
May 15, 2026Intimation In Relation To The Rights IssueMay 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2026
May 15, 2026Financial Results For The Quarter And Year Ended March 31 2026May 15, 2026
May 15, 2026Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Year Ended March 31 2026 And Unaudited Financial Results For The Quarter Ended March 31 2026.May 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 12, 2026
May 12, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 11, 2026
May 11, 2026Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)May 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2026
Apr 28, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Apr 09, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 08, 2026
Apr 08, 2026Intimation Regarding Dispatch Of The Second And Final Call Money Notice Of The Rights Equity Shares.Apr 07, 2026
Apr 07, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2026
Mar 25, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2026
Mar 25, 2026General Update - Rights Issue - Second & Final CallMar 24, 2026
Mar 24, 2026Corporate Action- Record Date For The Purpose Of Making Second And Final Call For Rights Equity SharesMar 24, 2026
Mar 24, 2026Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Aditya Birla Sun Life Flexi Cap Fund Direct-Growth | 0.09% | 0 | 0.00% | 0.00% | |
Aditya Birla Sun Life Manufacturing Equity Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.62% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.08% | 0 | 0.00% | 0.00% | |
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.01% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 37.31
ATR(14)
Less Volatile 24.80
STOCH(9,6)
Neutral 28.07
STOCH RSI(14)
Neutral 28.68
MACD(12,26)
Bearish -5.71
ADX(14)
Strong Trend 29.13
UO(9)
Bearish 37.57
ROC(12)
Downtrend And Accelerating -11.09
WillR(14)
Neutral -64.15
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
